Skip to main content

New Cancer Research Initiative Announced

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

THURSDAY, July 27, 2023 -- The Biden administration on Thursday launched a new research program aimed at helping doctors to better distinguish cancer cells from healthy tissue during surgery.

The program will fall under the purview of the Advanced Research Projects Agency for Health (ARPA-H). The agency was first formed in March 2022 as part of Biden's Cancer Moonshot initiative.

"Surgical procedures are often the first treatment option for the approximately 2 million Americans diagnosed with cancer each year," the White House said in a statement announcing the new program. "However, current surgical technologies do not allow doctors to easily and fully distinguish cancer cells from normal surrounding tissue in the operating room. This can lead to repeat surgeries, a more difficult recovery, and cancer recurrence, as well as higher health care costs."

The new initiative could improve cancer treatments and lead to new breakthroughs, Arati Prabhakar, director of the White House Office of Science and Technology Policy, told the Associated Press. "What's true is that many cancer treatments still start with surgery," she said. "So, being really smart and attacking and developing new technology to make that first step better could really revolutionize how we are able to treat cancer for so many Americans."

Prabhakar added that usually federal research money goes to university or government labs, but ARPA-H programs will search more broadly. "The mission is to reach for things that aren't that obvious or feasible today -- and to do that, you have to take risks," Prabhakar said. "The process allows you to explore things that could have a bigger impact if they do work and very often what I have seen is that the overall program succeeds even though some of the individual pieces don't succeed."

ARPA-H has placed an open call for other research objectives, Danielle Carnival, coordinator of the White House Cancer Moonshot program, told the AP. The agency's work is a "central pillar" of the administration's plans to meet its goal of cutting cancer deaths. "I would expect some really great ideas and new projects to come out of that call," Carnival said.

Associated Press Article

Statement From President Joe Biden

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Vaginal Cancer Incidence Increasing Globally

WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.